C10027309 / invoice 10000
Species:CANINE
Breed:Chihuahua
Age (years):7
Diagnosis or signs:Medication
Consult notes
Animal clinical history (3 most recent)
2026-03-13T00:00:00Z 2:20 PM
Reason: Vetnostics Results Received & Attached - ZoeLaboratory: Specimen Catheter CHEMISTRY MICROSCOPY pH 5.0 Leucocytes > 100 x10/L (< 10) 6 Protein Erythrocytes > 100 x10/L (< 10) +++ 6 Glucose nil Epithelial cells 40 x10/L (< 10) 6 Blood Bacteria numerous +++ Ketones nil Bilirubin nil Crystals: No crystals seen. Specific Gravity: 1.011 Heavy growth (>10^8 CFU/L) CULTURE Org 1: E.coli SUSCEPTIBILITY Ampi/Amoxycillin R Enrofloxacin S Cephalexin R Sulpha/Trimeth S Doxycycline S Clavulan/Amox R Marbofloxacin SMICROSCOPIC EXAMINATIONAcross the smears examined, cytological findings revealed numerous neutrophils (some of which appeared degenerate and some of which contained short bacterial rods within their cytoplasm). Occasional intact urothelial cells (some which occasionally displayed mild anisocytosis and anisokaryosis) were also scattered freely throughout the background of the cytospin smear examined. A moderately to markedly increased population of short bacterial rods was also seen scattered freely as well as in short chains and clumps throughout the background of the cytospin smear examined. Occasional squames were also present (likely secondary to collection technique). DIAGNOSIS Marked pyuria and moderate to marked bacteriuria COMMENT Please refer to culture results to further investigate the significance of the microbial component associated with this urinary tract infection more closely. Urothelial cells displaying mild anisocytosis and anisokaryosis did not exclude the possibility of underlying epithelial neoplasia-particularly if there has been no significant response to appropriate antimicrobial therapy and there is no obvious evidence of urolithiasis-although urothelial cells in the presence of a significant inflammatory/infective process or chronic persistent irritation (e.g. urolithiasis) may undergo dysplastic change which may mimic neoplasia. Please refer to urinalysis report for further investigation.Treatment:Enrofloxacin 50mg PO SID Client communication: STO and relayed pathology results. Advise can pick up antibiotics from reception area Vital Signs
Previous claim history (8)
| Date | Claim # | Diagnosis |
|---|---|---|
| 2026-03-11 | C10018655 | POLYURIA/POLYDIPSIA - PRESENTING COMPLAINT |
| 2026-03-01 | C09970118 | URINARY TRACT INFECTION (UTI) |
| 2025-06-24 | C8879154 | Grooming |
| 2025-06-20 | C8862190 | POLYDIPSIA - PRESENTING COMPLAINT |
| 2025-02-28 | C8391442 | VOMITING - OTHER - PRESENTING COMPLAINT |
| 2025-02-28 | C8391442 | HEART MURMUR |
| 2025-02-28 | C8418364 | BLOOD SCREEN |
| 2025-02-28 | C8418364 | ALTERNATIVE THERAPIES |
Line items(lines with upstream diagnosis are skipped by the model)
| Line | tstarc | Amount | Date | Upstream diagnosis |
|---|---|---|---|---|
| 10000 | tstarc_antibiotics_-_enrofloxacin | 76.50 | 2026-03-13 | — |
UPM+
- DG01885URINARY TRACT INFECTION (UTI)DSTP_urinary_infection_or_cystitis
Variant (sleepy_king)
URINARY TRACT INFECTION (UTI)
DSTP_urinary_infection_or_cystitis
Conf: 0.940
Threshold: 0.43
Above: ✓
Correct?